Table 1.
Distribution of the Studied Cases According to Different Parameters (n = 36).
| No. (%) | Mean ± SD | Median (min.–max.) | |
|---|---|---|---|
| Gender | |||
| Male | 13 (36.1) | ||
| Female | 23 (63.9) | ||
| Age (years) | 71 ± 10.8 | 70 (40–91) | |
| Educational level | |||
| Primary school or less | 10 (27.8) | ||
| High school | 15 (41.6) | ||
| University | 11 (30.6) | ||
| Diagnosis | |||
| MCI | 3 (8.3) | ||
| PDD | 7 (19.4) | ||
| DLB | 2 (5.6) | ||
| Alzheimer’s disease | 17 (47.2) | ||
| Mixed dementia | 7 (19.4) | ||
| Disease duration (months) | 34.6 ± 29 | 24 (11–140) | |
| Marital status | |||
| Single | 3 (8.3) | ||
| Married | 20 (55.6) | ||
| Divorced | 3 (8.3) | ||
| Widow | 10 (27.8) | ||
| Treatment | |||
| No | 4 (11.1) | ||
| Yes | 32 (88.9) | ||
| Memantine | 20 (55.6) | ||
| Donepezil | 8 (22.2) | ||
| Rivastigmine | 18 (50) | ||
| Comorbidity | |||
| No | 10 (27.8) | ||
| Yes | 26 (72.2) | ||
| Cancer | 1 (2.8) | ||
| Diabetes mellitus | 15 (41.7) | ||
| Hypertension | 20 (55.6) | ||
| Stroke | 5 (13.9) | ||
| Thyroid disease | 1 (2.8) | ||
| Depression | 9 (25) | ||
| COVID 19 infection | 1 (2.8) | ||
| Cognitive domains decline | |||
| Orientation | 0.4 ± 0.5 | 0 (0–1) | |
| Memory | 1.5 ± 0.8 | 1.5 (0–3) | |
| Attention and calculation | 0.5 ± 0.6 | 0 (0–2) | |
| Language | 0.2 ± 0.4 | 0 (0–1) | |
| Design copying | 0.2 ± 0.4 | 0 (0–2) | |
| Compliance to treatment | 31 (86.1) | ||
| MMSE scores | |||
| Initial | 20.9 ± 3.9 | 22 (10–26) | |
| Before lockdown | 17.3 ± 4.9 | 18 (8–25) | |
| MCI | 3 (8.3) | ||
| Mild dementia | 13 (36.1) | ||
| Moderate dementia | 17 (47.2) | ||
| Severe dementia | 3 (8.3) | ||
| After lockdown | 13.9 ± 4.9 | 14 (5–24) | |
| MCI | 2 (5.6) | ||
| Mild dementia | 8 (22.2) | ||
| Moderate dementia | 19 (52.8) | ||
| Severe dementia | 7 (19.4) | ||
| PHQ-9 | 3.9 ± 3.5 | 3 (0–16) | |